Klebsiella oxytoca expands in cancer cachexia and acts as a gut pathobiont contributing to intestinal dysfunction

Cancer cachexia is a complex multi-organ syndrome characterized by body weight loss, weakness, muscle atrophy and fat depletion. With a prevalence of 1 million people in Europe and only limited therapeutic options, there is a high medical need for new approaches to treat cachexia. Our latest results...

Descripción completa

Detalles Bibliográficos
Autores principales: Pötgens, Sarah A., Brossel, Hélène, Sboarina, Martina, Catry, Emilie, Cani, Patrice D., Neyrinck, Audrey M., Delzenne, Nathalie M., Bindels, Laure B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098145/
https://www.ncbi.nlm.nih.gov/pubmed/30120320
http://dx.doi.org/10.1038/s41598-018-30569-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6098145/
https://www.ncbi.nlm.nih.gov/pubmed/30120320
http://dx.doi.org/10.1038/s41598-018-30569-5

Ejemplares similares